Ispire Technology reported fiscal first-quarter revenue of $27.5 million, down 9.3% from $30.4 million a year earlier, primarily due to lower European sales amid tighter vaping regulations. Net loss widened to $6.4 million from $3.3 million, including $4.8 million in credit loss expenses. Gross margin was 16.2%, down from 17% a year earlier but up from 6.3% in the previous quarter. Adjusted EBITDA was positive $136,000, compared with $639,000 a year earlier.
The company said it is expanding manufacturing in Malaysia and pursuing new OEM and ODM relationships, including a potential deal with a regional Southeast Asian brand. Ispire is also advancing its nicotine pouch joint venture with Jincheng Pharma and plans a U.S. pilot of its IKE 2.0 age-gating platform with Charlie’s Holdings. Ispire ended the quarter with $15.6 million in cash and $400,000 in working capital.
